| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Stanczyk FZ et al. | Effect of oral contraceptives containing 20 and 35 micrograms ethinyl estradiol on urinary prostacyclin and thromboxane metabolite levels in smokers and nonsmokers. | 1999 | Contraception | pmid:10342082 |
| Campos MG et al. | The androgenic effect of norethisterone and 5alpha-norethisterone on the contractile response of the rat vas deferens to methoxamine and serotonin. | 1999 | Life Sci. | pmid:10350363 |
| Johansson ED and Kral JG | Oral contraceptives after intestinal bypass operations. | 1976 | JAMA | pmid:1036586 |
| Gerhards E et al. | Studies of the kinetics and metabolism of 17 beta-heptanoyl-17 alpha-ethinyl-4-oestren-3-one-7-3H (norethisterone enanthate) in humans following intramuscular injection. | 1976 | Arzneimittelforschung | pmid:1036962 |
| Wahrenberg H et al. | Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome. | 1999 | J. Clin. Endocrinol. Metab. | pmid:10372729 |
| Khan AR et al. | Experience with norethisterone enanthate as injectable contraceptive. | 1976 | Bangladesh Med Res Counc Bull | pmid:1037371 |
| Sulak P et al. | Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction. | 1999 | Contraception | pmid:10382078 |
| Mattsson LA et al. | Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations. | 1999 | Obstet Gynecol | pmid:10389719 |
| Adamczyk M et al. | O-(fluoresceinylmethyl)hydroxylamine (OFMHA): a reagent for the preparation of fluorescent O-(fluoresceinylmethyl)oxime (FMO)-steroid conjugates. | 1999 | Steroids | pmid:10399885 |
| Eriksen EF et al. | Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women. | 1999 | J. Bone Miner. Res. | pmid:10404024 |
| Vestergaard P et al. | Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study. | 1999 | J. Clin. Endocrinol. Metab. | pmid:10404791 |
| Duncan AC et al. | The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women. | 1999 | J. Clin. Endocrinol. Metab. | pmid:10404811 |
| Geisler J et al. | Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking. | 1999 | J. Endocrinol. | pmid:10425465 |
| Paul AC and Choy CC | Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. | 1999 | Br J Obstet Gynaecol | pmid:10430209 |
| van Hoof HJ et al. | Female sex hormone replacement therapy increases serum free 1,25-dihydroxyvitamin D3: a 1-year prospective study. | 1999 | Clin. Endocrinol. (Oxf) | pmid:10468912 |
| Gravholt CH et al. | Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status. | 1999 | Clin. Endocrinol. (Oxf) | pmid:10468952 |
| Archer DF et al. | Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Endometrium Study Group. | 1999 | Obstet Gynecol | pmid:10472853 |
| Rugarn O et al. | Effects of estradiol, progesterone, and norethisterone on regional concentrations of galanin in the rat brain. | 1999 | Peptides | pmid:10477130 |
| Engmann L et al. | Progestogen therapy during pituitary desensitization with gonadotropin-releasing hormone agonist prevents functional ovarian cyst formation: a prospective, randomized study. | 1999 | Am. J. Obstet. Gynecol. | pmid:10486466 |
| Alexandersen P et al. | Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study. | 1999 | J. Clin. Endocrinol. Metab. | pmid:10487657 |